Q4 2023 Holdings
Filed 2024-02-14 | 123 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $91.5M | 1,558,059 | 8.5% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $65.2M | 2,199,137 | 6.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $44.6M | 2,204,797 | 4.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $42.1M | 3,440,345 | 3.9% |
| Lianbio | SPONSORED ADS | 53000N108 | $41.9M | 9,366,783 | 3.9% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $41.8M | 1,950,609 | 3.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $33.6M | 1,137,107 | 3.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $32.6M | 3,097,399 | 3.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $30.9M | 2,750,000 | 2.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $27.7M | 405,600 | 2.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $25.5M | 320,000 | 2.4% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $24.8M | 900,000 | 2.3% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $22.0M | 2,191,417 | 2.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $19.5M | 679,630 | 1.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $18.8M | 300,000 | 1.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $17.5M | 30,000 | 1.6% |
| New York Cmnty Bancorp Inc(NYCBEUR) | COM | 649445103 | $16.4M | 1,606,600 | 1.5% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $15.8M | 220,000 | 1.5% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $15.3M | 85,000 | 1.4% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $15.2M | 1,079,528 | 1.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $15.1M | 692,925 | 1.4% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $13.5M | 215,000 | 1.2% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $13.2M | 3,255,026 | 1.2% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $12.4M | 4,076,741 | 1.1% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.4M | 170,000 | 1.1% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $11.4M | 1,100,000 | 1.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $11.1M | 300,000 | 1.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $10.5M | 600,000 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $10.2M | 6,550,000 | 0.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.1M | 200,000 | 0.9% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $9.5M | 350,000 | 0.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $9.2M | 110,000 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $8.8M | 70,000 | 0.8% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $8.8M | 271,200 | 0.8% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $8.3M | 350,000 | 0.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $8.1M | 1,000,000 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $7.9M | 771,138 | 0.7% |
| Moderna Inc(MRNA) | COM | 60770K107 | $7.6M | 76,700 | 0.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $7.5M | 250,000 | 0.7% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $6.5M | 2,491,780 | 0.6% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $6.2M | 2,524,076 | 0.6% |
| Kinnate Biopharma Inc | COM | 49705R105 | $6.2M | 2,601,647 | 0.6% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $6.1M | 1,360,000 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $6.1M | 200,000 | 0.6% |
| CVB Finl Corp(CVBF) | COM | 126600105 | $6.1M | 300,000 | 0.6% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $6.0M | 741,514 | 0.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $6.0M | 140,000 | 0.6% |
| Equity Comwlth(HP5A) | COM SH BEN INT | 294628102 | $5.8M | 300,000 | 0.5% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $5.5M | 1,850,000 | 0.5% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $5.3M | 3,330,000 | 0.5% |